| Literature DB >> 27974637 |
Jacqueline Thorburn1, Leah Staskiewicz1, Megan L Goodall1, Lina Dimberg1, Arthur E Frankel1, Heide L Ford1, Andrew Thorburn2.
Abstract
Autophagy, the mechanism by which cells deliver material to the lysosome, has been associated with resistance to anticancer drugs, leading autophagy inhibition to be widely studied as a potential chemosensitization strategy for cancer cells. This strategy is based on the idea that inhibition of autophagy will increase drug sensitivity and kill more cancer cells. Here we report an unintended negative effect of this strategy. When modeling the effect of drug resistance in a heterogeneous cancer cell population, we found that autophagy inhibition in drug-sensitive tumor cells causes increased growth of drug-resistant cells in the population through a mechanism involving caspase activation and prostaglandin E2 signaling. These results emphasize the importance of understanding how autophagy manipulation in a tumor cell can have both cell-autonomous and nonautonomous effects and suggest that attempts to chemosensitize by inhibiting autophagy could be enhanced by adopting methods aimed at reducing tumor repopulation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27974637 PMCID: PMC5198514 DOI: 10.1124/mol.116.106070
Source DB: PubMed Journal: Mol Pharmacol ISSN: 0026-895X Impact factor: 4.436